Literature DB >> 21969000

Naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs48/45 and Pfs230 in an area of seasonal transmission.

André Lin Ouédraogo1, Will Roeffen, Adrian J F Luty, Sake J de Vlas, Issa Nebie, Edith Ilboudo-Sanogo, Nadine Cuzin-Ouattara, Karina Teleen, Alfred B Tiono, Sodiomon Bienvenu Sirima, Jan-Peter Verhave, Teun Bousema, Robert Sauerwein.   

Abstract

Acquisition of immunity to Plasmodium falciparum sexual stages is a key determinant for reducing human-mosquito transmission by preventing the fertilization and the development of the parasite in the mosquito midgut. Naturally acquired immunity against sexual stages may therefore form the basis for the development of transmission-blocking vaccines, but studies conducted to date offer little in the way of consistent findings. Here, we describe the acquisition of antigametocyte immune responses in malaria-exposed individuals in Burkina Faso. A total of 719 blood samples were collected in a series of three cross-sectional surveys at the start, peak, and end of the wet season. The seroprevalence of antibodies with specificity for the sexual stage antigens Pfs48/45 and Pfs230 was 2-fold lower (22 to 28%) than that for an asexual blood stage antigen glutamate-rich protein (GLURP) (65%) or for the preerythrocytic stage antigen circumsporozoite protein (CSP) (54%). The youngest children responded at frequencies similar to those for all four antigens but, in contrast with the immune responses to GLURP and CSP that increased with age independently of season and area of residence, there was no evidence for a clear age dependence of responses to Pfs48/45 and Pfs230. Anti-Pfs230 antibodies were most prevalent at the peak of the wet season (P < 0.001). Our findings suggest that naturally acquired immunity against Pfs48/45 and Pfs230 is a function of recent exposure rather than of cumulative exposure to gametocytes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21969000      PMCID: PMC3232645          DOI: 10.1128/IAI.05288-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

1.  Transmission-blocking immunity to Plasmodium falciparum in malaria-immune individuals is associated with antibodies to the gamete surface protein Pfs230.

Authors:  J Healer; D McGuinness; R Carter; E Riley
Journal:  Parasitology       Date:  1999-11       Impact factor: 3.234

Review 2.  Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination.

Authors:  Teun Bousema; Chris Drakeley
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

Review 3.  Acquired immunity and vaccination in malaria.

Authors:  S Cohen; G A Butcher; G H Mitchell; J A Deans; J Langhorne
Journal:  Am J Trop Med Hyg       Date:  1977-11       Impact factor: 2.345

4.  Cultivation of fertile Plasmodium falciparum gametocytes in semi-automated systems. 1. Static cultures.

Authors:  T Ponnudurai; A H Lensen; A D Leeuwenberg; J H Meuwissen
Journal:  Trans R Soc Trop Med Hyg       Date:  1982       Impact factor: 2.184

5.  Field evaluation of an enzyme-linked immunosorbent assay (ELISA) for Plasmodium falciparum sporozoite detection in anopheline mosquitoes from Kenya.

Authors:  J C Beier; P V Perkins; R A Wirtz; R E Whitmire; M Mugambi; W T Hockmeyer
Journal:  Am J Trop Med Hyg       Date:  1987-05       Impact factor: 2.345

6.  Target antigens of malaria transmission blocking immunity exist as a stable membrane bound complex.

Authors:  N Kumar
Journal:  Parasite Immunol       Date:  1987-05       Impact factor: 2.280

7.  Malaria transmission-blocking immunity induced by natural infections of Plasmodium vivax in humans.

Authors:  K N Mendis; Y D Munesinghe; Y N de Silva; I Keragalla; R Carter
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

8.  Malaria transmission and naturally acquired immunity to PfEMP-1.

Authors:  K P Piper; R E Hayward; M J Cox; K P Day
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

9.  Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito.

Authors:  A N Vermeulen; T Ponnudurai; P J Beckers; J P Verhave; M A Smits; J H Meuwissen
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

10.  Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya.

Authors:  J Teun Bousema; Louis C Gouagna; Chris J Drakeley; Annemiek M Meutstege; Bernard A Okech; Ikupa N J Akim; John C Beier; John I Githure; Robert W Sauerwein
Journal:  Malar J       Date:  2004-06-17       Impact factor: 2.979

View more
  47 in total

Review 1.  The s48/45 six-cysteine proteins: mediators of interaction throughout the Plasmodium life cycle.

Authors:  Silvia A Arredondo; Stefan H I Kappe
Journal:  Int J Parasitol       Date:  2016-11-27       Impact factor: 3.981

2.  Identification of three ookinete-specific genes and evaluation of their transmission-blocking potentials in Plasmodium berghei.

Authors:  Wenqi Zheng; Xu Kou; Yunting Du; Fei Liu; Chunyun Yu; Takafumi Tsuboi; Qi Fan; Enjie Luo; Yaming Cao; Liwang Cui
Journal:  Vaccine       Date:  2016-04-12       Impact factor: 3.641

Review 3.  Evaluation of the Pfs25-IMX313/Matrix-M malaria transmission-blocking candidate vaccine in endemic settings.

Authors:  Charles Mulamba; Chris Williams; Katharina Kreppel; Jean Bosco Ouedraogo; Ally I Olotu
Journal:  Malar J       Date:  2022-06-02       Impact factor: 3.469

Review 4.  Plasmodium Gametocytes in Field Studies: Do We Measure Commitment to Transmission or Detectability?

Authors:  Cristian Koepfli; Guiyun Yan
Journal:  Trends Parasitol       Date:  2018-03-12

Review 5.  Plasmodium falciparum gametocyte transit through the cutaneous microvasculature: A new target for malaria transmission blocking vaccines?

Authors:  Christian P Nixon
Journal:  Hum Vaccin Immunother       Date:  2016-05-16       Impact factor: 3.452

6.  Dimorphism in genes encoding sexual-stage proteins of Plasmodium ovale curtisi and Plasmodium ovale wallikeri.

Authors:  Mary C Oguike; Colin J Sutherland
Journal:  Int J Parasitol       Date:  2015-03-24       Impact factor: 3.981

7.  Immunoreactivity of Sera From Low to Moderate Malaria-Endemic Areas Against Plasmodium vivax rPvs48/45 Proteins Produced in Escherichia coli and Chinese Hamster Ovary Systems.

Authors:  Myriam Arévalo-Herrera; Kazutoyo Miura; Nora Cespedes; Carlos Echeverry; Eduardo Solano; Angélica Castellanos; Juan Sebastián Ramirez; Adolfo Miranda; Andrey V Kajava; Carole Long; Giampietro Corradin; Sócrates Herrera
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

8.  Mechanistic within-host models of the asexual Plasmodium falciparum infection: a review and analytical assessment.

Authors:  Flavia Camponovo; Tamsin E Lee; Jonathan R Russell; Lydia Burgert; Jaline Gerardin; Melissa A Penny
Journal:  Malar J       Date:  2021-07-10       Impact factor: 2.979

9.  Qualification of standard membrane-feeding assay with Plasmodium falciparum malaria and potential improvements for future assays.

Authors:  Kazutoyo Miura; Bingbing Deng; Gregory Tullo; Ababacar Diouf; Samuel E Moretz; Emily Locke; Merribeth Morin; Michael P Fay; Carole A Long
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

10.  Plasmodium falciparum Gametocyte-Specific Antibody Profiling Reveals Boosting through Natural Infection and Identifies Potential Markers of Gametocyte Exposure.

Authors:  Jeff Skinner; Chiung-Yu Huang; Michael Waisberg; Philip L Felgner; Ogobara K Doumbo; Aissata Ongoiba; Kassoum Kayentao; Boubacar Traore; Peter D Crompton; Kim C Williamson
Journal:  Infect Immun       Date:  2015-08-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.